We have completed Phase II of IPAK Vaxxed vs. Unvaxxed Study. To support Phase 3, considering joining those who donate monthly to IPAK by becoming an IPAK Monthly Science Hero (Click here).
IPAK Vaxxed vs. Unvaxxed Study Phase II Publication
Revisiting Excess Diagnoses of Illnesses and Conditions in Children Whose Parents Provided Informed Permission to Vaccinate Them Int J Vacc Res Theor Pract, 2(2) https://doi.org/10.56098/ijvtpr.v2i2.59 https://ijvtpr.com/index.php/IJVTPR/article/view/59
In Phase III, we are addressing the following questions:
1. Are specific adverse health outcomes associated with aluminum-containing vaccines?
2. Are there differences between the vaccinated and unvaccinated patients with respect to the age of onset of specific vaccine-associated health outcomes?
3. Is the receipt of >1 vaccine per well-child visit associated with increased risk of new diagnoses of potential adverse health outcomes.
There are questions that remain such as health outcomes associated with live vs. non-live vaccines, aluminum-containing vaccines vs. non-aluminum containing vaccines, as well as studying the impact of individual vaccines on specific health outcome risks.
